SV2C and Parkinson disease: For example, the brain expression of SLC6A3 (Habak et al., 2014), SYNGR3 (Ho et al., 2023), DDC (Pereira et al., 2023), and SV2C (Dunn et al., 2017) has been shown to modulate dopamine neurotransmission in PD models.